GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton, Dickinson and Co (XSWX:BDX) » Definitions » Beneish M-Score

Becton, Dickinson and Co (XSWX:BDX) Beneish M-Score : -2.55 (As of May. 06, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Becton, Dickinson and Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.55 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Becton, Dickinson and Co's Beneish M-Score or its related term are showing as below:

XSWX:BDX' s Beneish M-Score Range Over the Past 10 Years
Min: -2.99   Med: -2.57   Max: -0.89
Current: -2.55

During the past 13 years, the highest Beneish M-Score of Becton, Dickinson and Co was -0.89. The lowest was -2.99. And the median was -2.57.


Becton, Dickinson and Co Beneish M-Score Historical Data

The historical data trend for Becton, Dickinson and Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton, Dickinson and Co Beneish M-Score Chart

Becton, Dickinson and Co Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.63 -2.58 -2.70 -2.56 -2.41

Becton, Dickinson and Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.44 -2.45 -2.41 -2.60 -2.55

Competitive Comparison of Becton, Dickinson and Co's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton, Dickinson and Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Becton, Dickinson and Co's Beneish M-Score falls into.



Becton, Dickinson and Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Becton, Dickinson and Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0385+0.528 * 1.0974+0.404 * 0.9724+0.892 * 0.9804+0.115 * 1.0389
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9559+4.679 * -0.03715-0.327 * 1.0047
=-2.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was CHF2,274 Mil.
Revenue was 4482.987 + 4069.749 + 4576.265 + 4392.151 = CHF17,521 Mil.
Gross Profit was 2047.334 + 1752.95 + 1530.22 + 1890.84 = CHF7,221 Mil.
Total Current Assets was CHF9,188 Mil.
Total Assets was CHF48,124 Mil.
Property, Plant and Equipment(Net PPE) was CHF5,857 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF2,035 Mil.
Selling, General, & Admin. Expense(SGA) was CHF4,204 Mil.
Total Current Liabilities was CHF6,511 Mil.
Long-Term Debt & Capital Lease Obligation was CHF14,213 Mil.
Net Income was 477.178 + 243.009 + 97.157 + 366.463 = CHF1,184 Mil.
Non Operating Income was -91.526 + -68.319 + -181.719 + -47.721 = CHF-389 Mil.
Cash Flow from Operations was 469.181 + 727.297 + 1191.97 + 972.432 = CHF3,361 Mil.
Total Receivables was CHF2,233 Mil.
Revenue was 4461.836 + 4272.318 + 4633.881 + 4502.698 = CHF17,871 Mil.
Gross Profit was 2068.493 + 1987.103 + 2021.544 + 2005.403 = CHF8,083 Mil.
Total Current Assets was CHF8,873 Mil.
Total Assets was CHF50,342 Mil.
Property, Plant and Equipment(Net PPE) was CHF5,882 Mil.
Depreciation, Depletion and Amortization(DDA) was CHF2,152 Mil.
Selling, General, & Admin. Expense(SGA) was CHF4,486 Mil.
Total Current Liabilities was CHF6,760 Mil.
Long-Term Debt & Capital Lease Obligation was CHF14,817 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2273.927 / 17521.152) / (2233.232 / 17870.733)
=0.129782 / 0.124966
=1.0385

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(8082.543 / 17870.733) / (7221.344 / 17521.152)
=0.452278 / 0.41215
=1.0974

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (9188.124 + 5856.763) / 48123.91) / (1 - (8872.769 + 5882.478) / 50341.647)
=0.687372 / 0.706898
=0.9724

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=17521.152 / 17870.733
=0.9804

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2152.252 / (2152.252 + 5882.478)) / (2034.737 / (2034.737 + 5856.763))
=0.267869 / 0.257839
=1.0389

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4204.323 / 17521.152) / (4486.238 / 17870.733)
=0.239957 / 0.251038
=0.9559

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((14213.157 + 6510.772) / 48123.91) / ((14817.255 + 6759.852) / 50341.647)
=0.430637 / 0.428613
=1.0047

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1183.807 - -389.285 - 3360.88) / 48123.91
=-0.03715

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Becton, Dickinson and Co has a M-score of -2.59 suggests that the company is unlikely to be a manipulator.


Becton, Dickinson and Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Becton, Dickinson and Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton, Dickinson and Co (XSWX:BDX) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.

Becton, Dickinson and Co (XSWX:BDX) Headlines